Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerda Egger

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate CancerValentin Al Jalali, Gabriel Wasinger, Sazan Rasul, et al.
Cancers|November 26, 2022
CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [<sup>68</sup>Ga]Ga-Pentixafor in CRC ImagingKatarína Benčurová, Joachim Friske, Maximilian Anderla, et al.
International Journal of Cancer|March 7, 2013
Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancerJulia Höbaus, Doris M Hummel, Ursula Thiem, et al.
The FEBS Journal|May 10, 2020
Attenuation of canonical NF-κB signaling maintains function and stability of human TregLiesa S Ziegler, Marlene C Gerner, Ralf L J Schmidt, et al.
Clinical Epigenetics|February 26, 2025
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT studyKilian Kluge, Vincent Lotz, Holger Einspieler, et al.
Cancers|December 10, 2021
Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate CancerRobert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, et al.
The Journal of Clinical Investigation|November 3, 2020
ALK-transformed mature T lymphocytes restore early thymus progenitor featuresAnnabelle Congras, Coralie Hoareau-Aveilla, Nina Caillet, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Molecular and Cellular Biology|December 24, 2009
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferationGordin Zupkovitz, Reinhard Grausenburger, Reinhard Brunmeir, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate CancerValentin Al Jalali, Gabriel Wasinger, Sazan Rasul, et al.
Cancers|November 26, 2022
CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [<sup>68</sup>Ga]Ga-Pentixafor in CRC ImagingKatarína Benčurová, Joachim Friske, Maximilian Anderla, et al.
International Journal of Cancer|March 7, 2013
Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancerJulia Höbaus, Doris M Hummel, Ursula Thiem, et al.
The FEBS Journal|May 10, 2020
Attenuation of canonical NF-κB signaling maintains function and stability of human TregLiesa S Ziegler, Marlene C Gerner, Ralf L J Schmidt, et al.
Clinical Epigenetics|February 26, 2025
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT studyKilian Kluge, Vincent Lotz, Holger Einspieler, et al.
Cancers|December 10, 2021
Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate CancerRobert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, et al.
The Journal of Clinical Investigation|November 3, 2020
ALK-transformed mature T lymphocytes restore early thymus progenitor featuresAnnabelle Congras, Coralie Hoareau-Aveilla, Nina Caillet, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Molecular and Cellular Biology|December 24, 2009
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferationGordin Zupkovitz, Reinhard Grausenburger, Reinhard Brunmeir, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
Pageof 9